Global Peptic Ulcer Market Size and Forecast 2024-2033 |Johnson & Johnson, Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A

The Peptic Ulcer Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Peptic Ulcer Market:

https://www.thebusinessresearchcompany.com/report/peptic-ulcer-global-market-report

According to The Business Research Company’s Peptic Ulcer Global Market Report 2024, The peptic ulcer  market size has grown steadily in recent years. It will grow from $3.94 billion in 2023 to $4.1 billion in 2024 at a compound annual growth rate (CAGR) of 4.0%.  The  growth in the historic period can be attributed to increased prevalence of helicobacter pylori infection, rising use of nonsteroidal anti-inflammatory drugs (nsaids), changing lifestyles and dietary habits, awareness campaigns and educational initiatives, focus on stress management.

The peptic ulcer  market size is expected to see steady growth in the next few years. It will grow to $4.69 billion in 2028 at a compound annual growth rate (CAGR) of 3.5%.  The growth in the forecast period can be attributed to emerging therapies and treatment modalities, increasing geriatric population, integration of precision medicine, preventive measures and health promotion, continued research and clinical trials. Major trends in the forecast period include digital health solutions, advancements in treatment modalitie, increasing prevalence of helicobacter pylori infection, integration of diagnostic imaging technologies, increasing use of combination therapies.

The growing prevalence of obesity is expected to propel the growth of the peptic ulcer market going forward. Obesity is a medical condition characterized by an excessive accumulation of body fat, typically resulting in an individual having a body mass index (BMI) of 30 or higher. Obesity can result from genetic, environmental, and lifestyle factors, such as a poor diet and a lack of physical activity. Obesity leads to the overproduction of stomach acid, weakens the stomach’s protective mucosal lining, and contributes to developing peptic ulcers. Moreover, excess weight seems to promote inflammation in the gut, which can lead to the development of peptic ulcers. For instance, in March 2022, according to the World Obesity Atlas 2022 report, the estimated global number of people with obesity (Class I, II, and III) ≥30kg/m2 in 2020 was 764 million, expected to increase to 892 million by 2025. Therefore, the growing prevalence of obesity is driving the growth of the peptic ulcer market.

Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample_request?id=13221&type=smp

The peptic ulcer market covered in this report is segmented –
1) By Disease Indication: Gastritis, Gastric Ulcer, Duodenal Ulcer, Gastroesophageal Reflux Disease (GERD)
2) By Drug Type: Proton Pump Inhibitors (PPI), H2 Antagonists, Antibiotics, Other Drugs
3) By Distribution Channel: Hospital Pharmacies, Private Clinics, Drug Store, Retail Pharmacies, E-commerce

Companies operating in the peptic ulcer market are developing innovative products and solutions and getting them approved by federal agencies to gain a competitive edge. Drug development is crucial in managing and treating peptic ulcers. It aids in symptom management, healing, preventing complications, and treating the underlying problem. For instance, in December 2021, the U.S. Food and Drug Administration approved Dartisla ODT. This new drug for peptic ulcer treatment aids functions by lessening symptoms. It is the first medication authorized as a supplement for treating peptic ulcer disease is Dartisla ODT. Dartisla ODT is known to have anticholinergic properties, as every tablet has been incorporated with 1.7 mg of glycopyrrolate.

The peptic ulcer market report table of contents includes:

1. Executive Summary

2. Peptic Ulcer Market Characteristics

3. Peptic Ulcer Market Trends And Strategies

4. Peptic Ulcer Market – Macro Economic Scenario

…

32. Global Peptic Ulcer Market Competitive Benchmarking

33. Global Peptic Ulcer Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Peptic Ulcer Market

35. Peptic Ulcer Market Future Outlook and Potential Analysis

 

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model